The OAC and OMC options

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue SUPPL. 2, 1999, Pages

  Unge, Peter ^a  

^a GÄVLE HOSPITAL   (Sweden)

Author keywords

Amoxycillin; Clarithromycin; Duodenal ulcer; Eradication; Gastric ulcer; H. pylori; Metronidazole; Omeprazole; Relapse; Resistance; Tolerability

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; ANTIULCER AGENT; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DOUBLE-BLIND METHOD; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; MULTICENTER STUDIES; OMEPRAZOLE; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0033176357     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199908002-00003     Document Type: Article

References (10)

1. The European Helicobacter Pylori Study Group. Current European concepts in the management of Helicobacter pylori infection - The Maastricht Consensus Report. Gut 1997; 41:8-13.
2. Lind T, Veldhuyzen van Zanten S, Unge P, Spiller R, Bayerdörffer E, O'Morain C, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH 1 study. Helicobacter 1996; 1:138-144.
3. Lind T, Mégraud F, Unge P, Bayerdörffer E, O'Morain C, Spiller R, et al. The MACH 2 study - role of omeprazole in eradication of Helicobacter pylori with one-week triple therapies: a randomised double-blind study. Gastroenterology 1999; 116:248-253.
4. Veldhuyzen van Zanten SJO, Bradette M, Farley A, Bayerdörffer E, Lind T, O'Morain C, et al. The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole-based triple therapy. Aliment Pharmacol Ther 1999; 13:289-295.
5. Malfertheiner P, Bayerdörffer E, Diete U, Gil J, Lind T, Misiuna P, et al. The GU-MACH study: the effect of one-week omeprazole triple therapy on Helicobacter pylori infection. Eradication, healing and relapse in patients with active gastric ulcer. Aliment Pharmacol Ther 1999; 13:703-712.
6. Moayyedi P, Sahay P, Tompkins DS, Axon ATR. Efficacy and optimum dose of omeprazole in a new 1 -week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995; 7:835-840.
7. Laine L, Frantz JE, Baker A, Neil GA. A United States multicentre trial of dual and proton pump inhibitor-based triple therapies for Helicobacter pylori. Aliment Pharmacol Ther 1997; 11:913-917.
8. Koelz HR, Beglinger C, Inauen W, Blum AL, Helico-Swiss-Study Group. Double-blind comparison of three different amoxicillin (amo) plus omeprazole (ome) regimens for eradication of Helicobacter pylori (Hp) in patients with peptic ulcer. Gastroenterology 1995; 108:A133.
9. Kimura K, Ido K, Saifuku K, Taniguchi Y, Satoh K, Takimoto T, et al. One-hour topical therapy for the eradication of H. pylori. Am J Gastroenterol 1994; 89:1403.
10. Labenz J, Blum A, Bayerdörffer E, Meining A, Stolte M, Börsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112:1442-1447.